Amgen Announces New Data Show Greater Bone Mineral Density Gains With Prolia vs Zoledronic Acid
October 11, 2015 at 20:26 PM EDT
Amgen (NASDAQ: AMGN) today announced findings from a randomized, double-blind, double-dummy, multicenter Phase 4 study showing that ...